CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica
Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.
CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica Read More »
News
Oculogica new patient opens potential CTE test for live subjects
Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology
Oculogica new patient opens potential CTE test for live subjects Read More »
Oculogica adds patent for assessment of Impairment due to Cannabis
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica adds patent for assessment of Impairment due to Cannabis Read More »
Oculogica receives DoD Grant for Development of Wearable concussion diagnostic
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic
Oculogica receives DoD Grant for Development of Wearable concussion diagnostic Read More »
Australia Grant Approves First Objective Concussion Diagnostic tool
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.
Australia Grant Approves First Objective Concussion Diagnostic tool Read More »
Oculogica Adds to IP Portfolio with Patent for Glaucoma
Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.
Oculogica Adds to IP Portfolio with Patent for Glaucoma Read More »
Dr. Uzma Samadani and Rosina Samadani Named to list of Most Creative People in Business
Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.
Dr. Uzma Samadani and Rosina Samadani Named to list of Most Creative People in Business Read More »
Fast Company: Samadani sisters invent better way to diagnosis concussion with eye tracking
Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.
EyeBOX Featured in Daily Show’s Trevor Noah with Microsoft President
Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.
EyeBOX Featured in Daily Show’s Trevor Noah with Microsoft President Read More »
Midwest Orthopaedics at Rush acquire Eye tracking technology for concussion
Midwest Orthopaedics at Rush (MOR) is the first in Illinois to offer a new eye-tracking technology to more quickly identify a patient with ocular changes after a potential concussion or traumatic brain injury.
Midwest Orthopaedics at Rush acquire Eye tracking technology for concussion Read More »